Unlocking the Potential of Condensin Complex (13S Condensin) as a Drug Target or Biomarker

Target Name: Condensin complex

NCBI ID: P17089

Condensin complex

Other Name(s): 13S condensin

Unlocking the Potential of Condensin Complex (13S Condensin) as a Drug Target or Biomarker

The condensin complex is a protein family that plays a crucial role in cell signaling and division. The 13S condensin complex is a subfamily that is particularly well-studied due to its involvement in various cellular processes, including cell division, apoptosis, and autophagy. This article will explore the potential of the 13S condensin complex as a drug target or biomarker, focusing on its structure, function, and potential therapeutic applications.

Structure and Function

The condensin complex is a protein complex that consists of multiple subunits that are held together by non-covalent interactions. The 13S condensin complex is a subfamily of condensins that is characterized by the presence of the protein 13S and its associated subunits.

The 13S condensin complex plays a vital role in regulating cell signaling and division. It is involved in the regulation of cell cycle progression, apoptosis, and autophagy. The complex functions by interacting with various cellular components, including the microtubules of the mitotic spindle, the centrosome, and the endoplasmic reticulum.

One of the most well-studied functions of the 13S condensin complex is its role in regulating cell division. The complex interacts with the microtubules of the

Protein Name: Condensin Complex

The "Condensin complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Condensin complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets